FDA NDC Directory · JSON-LD · Markdown

Famotidine

NDC 27241-249 · HUMAN PRESCRIPTION DRUG · FOR SUSPENSION

Labeler / ManufacturerAjanta Pharma USA Inc.
Marketing categoryAbbreviated NDA (generic) · App ANDA217529
Dosage form / routeFOR SUSPENSION · ORAL
Active ingredientsFAMOTIDINE (40 mg/5mL)
Marketing started20220425
Package count1

External sources

Source: openFDA. Public-domain (CC0).